You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 2, 2026

Drugs in ATC Class A12C


✉ Email this page to a colleague

« Back to Dashboard


Subclasses in ATC: A12C - OTHER MINERAL SUPPLEMENTS

Market Dynamics and Patent Landscape for ATC Class: A12C – Other Mineral Supplements

Last updated: January 4, 2026


Summary

This report offers an in-depth analysis of the current market landscape and patent environment surrounding the ATC (Anatomical Therapeutic Chemical) classification class A12C, which encompasses other mineral supplements. With growing consumer demand for nutritional and mineral supplementation driven by health awareness, aging populations, and preventive healthcare trends, the A12C category projects significant market traction. Concurrently, patent filings reveal strategic innovation trajectories among key industry players, emphasizing novel mineral formulations, delivery systems, and combination therapies.

This comprehensive overview provides stakeholders with actionable insights into market forces, patent activity, competitive positioning, regulatory considerations, and future trends.


What Is ATC Class A12C?

ATC Classification System Overview

  • The ATC system categorizes drugs and health products into groups based on their therapeutic use.
  • Class A12C specifies other mineral supplements, focusing on mineral formulations not classified under conventional mineral therapies.

Scope of A12C

  • Mineral compounds such as zinc, selenium, magnesium, and trace minerals.
  • Novel compositions, mineral blends, electrolytes, and mineral-enriched formulations used in healthcare, sports, and functional foods.

Market Dynamics for A12C Mineral Supplements

Global Market Size and Growth Trends

Year Market Value (USD Billion) CAGR (2022–2027) Key Drivers
2022 6.4 Rising health awareness
2027 (Projected) 9.8 8.8% Aging population, preventive care

Source: ResearchAndMarkets (2022) [1]

Key Market Segments

Segment Description Estimated Market Share (2022) Growth Drivers
Dietary Supplements Over-the-counter mineral pills and powders 65% Nutritional deficiency mitigation
Functional Food & Beverages Mineral-enriched foods (e.g., cereals, drinks) 20% Lifestyle health trends
Medical Nutritional Products Prescribed mineral therapies for deficiencies or conditions 15% Clinical nutrition, hospital use

Regional Analysis

Region Market Share (2022) CAGR (2022–2027) Notable Factors
North America 35% 8.2% High health consciousness, aging demographics
Europe 30% 8.5% Regulatory support, mature supplement industry
Asia-Pacific 20% 9.2% Growing middle class, traditional medicine influence
Latin America 10% 8.7% Increasing supplement adoption
MEA 5% 7.8% Emerging markets, regulatory variability

Market Drivers & Challenges

Drivers

  • Aging populations requiring mineral supplementation for osteoporosis, anemia, and metabolic health.
  • Preventive health focus fueling demand for self-medication products.
  • Increased consumer awareness of mineral deficiencies.
  • Regulatory approvals favoring dietary supplement markets.

Challenges

  • Stringent regulatory frameworks, especially in Europe and North America, restrict novel mineral formulations.
  • Market saturation due to numerous global and local players.
  • Bioavailability concerns and potential toxicity risks limit some mineral applications.

Patent Landscape for A12C: Strategic Innovations & Trends

Patent Filing Trends (2018–2023)

Year Number of Patent Filings Major Assignees Focus Areas
2018 120 Bayer, GlaxoSmithKline Novel mineral chelates, delivery systems
2019 150 Nestlé, Amway Mineral-enriched functional foods
2020 170 DSM, Unilever Encapsulation, sustained-release
2021 180 Pharmavite, Abbott Bioavailability enhancement
2022 200 Multiple SMEs & LPs Combination therapies, new formulations

(Source: Derwent Innovation, 2023)

Key Patent Themes

Theme Description Example Innovations
Mineral Chelate Complexes Improving absorption via chelation with amino acids or organic acids Zinc bisglycinate, Magnesium amino acid chelates
Delivery and Encapsulation Technologies Erm for targeted release, stability, and taste masking Liposomal delivery, Microencapsulation
Novel Mineral Combinations Synergistic effects, functional food enhancements Selenium + Zinc blends, Magnesium + Calcium
Bioavailability Enhancement Use of nanotechnology, insoluble mineral forms Nanoparticulate minerals, bio-sorption enhancers

Leading Patent Holders

Assignee Number of Patents (2022) Focus Areas
Bayer AG 45 Chelate formulations, delivery systems
DSM Nutritional Products 40 Functional fortification, bioavailability tech
Nestlé S.A. 30 Mineral-enriched food matrices
Unilever 25 Encapsulation, taste masking
Smaller innovative startups 50 Novel combinations, nanotech

Implications of Patent Trends

  • A large proportion of R&D invests in bioavailability and delivery innovations.
  • Increasing patent filings reflect market maturity, with players aiming for differentiation.
  • Patent activity suggests ongoing regulatory focus on safety, efficacy, and environmental impacts, influencing innovation directions.

Competitive Landscape and Regulatory Environment

Major Industry Players

Company Market Share (Estimated) Key Innovation Focus Notable Patents
Bayer AG ~15% Chelates, delivery systems Zinc bisglycinate patents
Nestlé S.A. ~12% Functional foods, bioavailability Mineral-enriched formulas
DSM ~10% Bioavailability, fortification Mineral encapsulation patents
Amway ~8% Dietary supplements, combinations Novel mineral blends
Small & Medium Innovators Remaining share Nanotech, unique formulations Multiple filings

Regulatory Landscape Overview

  • FDA (U.S.): Dietary supplements classified under DSHEA (1994). Requires safety, structure-function claims regulation.
  • EFSA (European Union): Stringent scientific assessment for health claims. Novel minerals require novel food authorization.
  • Asia-Pacific: Regulatory frameworks vary, with countries like China and Japan enabling fast-track approvals for traditional or novel mineral products.

Impacts on Patent & Market Strategy

  • Companies pursue patent protection to navigate regulatory hurdles.
  • Innovation in delivery and formulation serves as key differentiator under regulation.
  • Compliance influences R&D pipelines and marketing claims.

Future Trends and Opportunities

Trends Opportunities Challenges
Personalized mineral therapy Precision formulations based on genetic, dietary profiling Regulatory and data privacy considerations
Nanotechnology-based mineral delivery Enhanced bioavailability, targeted release Safety and environmental concerns
Combination supplements with other nutrients Synergistic effects, expanded health claims Complexity of patent landscape, safety
Sustainable sourcing and eco-friendly production Regulatory favorability and consumer preference Supply chain adaptation
Regulatory harmonization Simplified approval pathways Jurisdictional disparities

Key Regulatory and Innovation Comparisons

Factor North America Europe Asia-Pacific
Regulatory Body FDA EFSA Varies (e.g., CFDA)
Approval Pathway Dietary supplement registration Novel food authorization Varies, often faster
Focus of Innovation Delivery systems, combinations Safety, claim substantiation Traditional and modern formulations
Market Entry Challenges Label claims, safety standards Stringent approval processes Market-specific standards

Conclusion

The A12C class—other mineral supplements—represents a rapidly evolving sector, driven by consumer health trends and technological innovation. Market growth is supported by aging demographics, preventive healthcare practices, and functional food markets, with North America and Europe leading. The patent landscape reveals robust activity in formulation science, delivery mechanisms, and combination therapies, indicating sustained R&D investments and strategic positioning by industry players.

Despite regulatory challenges, innovation trajectories suggest significant opportunities, especially in personalized therapies, nanotech applications, and sustainable sourcing. Stakeholders should monitor patent filings, regulatory shifts, and emerging consumer preferences to sustain competitive advantage.


Key Takeaways

  • The global mineral supplement market is projected to grow at a CAGR of approximately 8.8% through 2027, reaching nearly USD 10 billion.
  • Patent activity over the past five years reflects a focus on bioavailability, delivery technology, and novel mineral combinations.
  • Leading industry players dominate patent filings, with Bayer, DSM, and Nestlé at the forefront.
  • Regulatory environments in different regions influence product development, especially regarding safety and health claims.
  • Future trends point toward personalized, nanotechnology-based, and sustainable mineral supplement innovations.

FAQs

1. What are the primary minerals covered under ATC Class A12C?
Minerals such as zinc, magnesium, selenium, calcium, and trace minerals are central to A12C, often formulated as chelates or in functional combinations for enhanced absorption.

2. How does patent activity influence market competition in mineral supplements?
High patent activity signifies innovation leadership, barriers to entry for newcomers, and strategic positioning for higher market share in emerging niches like nanotech and personalized therapies.

3. What regulatory hurdles do mineral supplement innovators face?
Regulatory challenges include demonstrating safety, efficacy, and bioavailability; obtaining health claims approval; and complying with differing standards across jurisdictions.

4. Which regions are leading in mineral supplement innovation and adoption?
North America and Europe constitute the primary markets, with Asia-Pacific rapidly growing due to urbanization, increasing health awareness, and favorable government policies.

5. How will future innovations reshape the mineral supplement landscape?
Advancements in nanotechnology, personalized formulations, and sustainable sourcing will enable more effective, targeted, and environmentally friendly products, fostering competitive differentiation.


References

[1] ResearchAndMarkets. (2022). Global Mineral Supplements Market — Growth, Trends, and Forecasts (2022-2027).

[Additional references would include patent databases, regulatory agency reports, and industry publications as necessary]

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.